ACER - オペクサ・セラピュ―ティクス (Acer Therapeutics Inc.) オペクサ・セラピュ―ティクス

 ACERのチャート


 ACERの企業情報

symbol ACER
会社名 Acer Therapeutics Inc (オペクサ・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 オペクサ・セラピューティクス(Opexa Therapeutics Inc)はバイオ医薬品企業。同社は多発性硬化症(MS)などの疾患に対する治療の可能性のある個別化細胞療法の開発に従事する。それらの治療法は同社のT細胞技術をベースとしている。同社の主な製品候補であるTovaxinはベーラー医科大学(Baylor College of Medicine)からライセンスを受けた、MS治療用の臨床開発中の個別化T細胞治療ワクチンである。TcelnaはT細胞の免疫療法であり、IIb期臨床開発中の二次進行型MS(SPMS)治療用に使用される。Tcelnaは患者の疾患プロファイルに特に合わせる個人向け治療法である。TERMS研究は臨床分離症候群リスクの高いあるいは再発寛解型多発性硬化症(RRMS)を患っている150位患者を対象とする多中心の無作為プラセボ比較二重盲検臨床試験である。   オペクサ・セラピュ―ティクスは米国のバイオ医薬品会社。多発性硬化症(MS)など重篤な疾病、及び視神経脊髄炎などの免疫性疾患の自己免疫療法の開発に従事。独自に開発したT細胞技術に基づき、二次進行型MSや再発寛解型MSなどの治療薬の臨床開発段階にある。また、血液から単球由来幹細胞を生成するための成体幹細胞技術を開発。本社はテキサス州。   Acer Therapeutics, Inc. is a pharmaceutical company. The firm engages in the acquisition, development and commercialization of therapies for medical needs. Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling on September 19, 2017 and is headquartered in Newton, MA.
本社所在地 One Gateway Center Suite 351 300 Washington St. Newton MA 02458 USA
代表者氏名
代表者役職名
電話番号
設立年月日 33298
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 6人
url www.acertx.com
nasdaq_url https://www.nasdaq.com/symbol/acer
adr_tso
EBITDA EBITDA(百万ドル) -16.45878
終値(lastsale) 28.37
時価総額(marketcap) 285203269.56
時価総額 時価総額(百万ドル) 282.99160
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 274.64783
当期純利益 当期純利益(百万ドル) -16.51118
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Acer Therapeutics Inc revenues was not reported. Net loss increased 36% to $8.8M. Higher net loss reflects General and administrative increase from $1.5M to $4.1M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.01 to -$1.18.

 ACERのテクニカル分析


 ACERのニュース

   Acer Therapeutics rallies on encouraging ACER-001 data (NASDAQ:ACER)  2020/07/09 12:22:05 Seeking Alpha
Thinly traded nano cap Acer Therapeutics (NASDAQ:ACER) jumps 20% premarket on modestly higher volume in reaction to results from a food effect study in 36
   The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Acer Therapeutics Inc. Investors (ACER)  2020/06/24 17:53:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $ACER #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Acer Therapeutics Inc. (“Acer” or the “Company”) (NASDAQ: ACER) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click here to participate. On June 25, 2019, the Company disclosed receipt of a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration rejecting its new drug application for EDSIVO,
   Acer Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update  2020/05/14 20:01:00 GlobeNewswire
Expanded pipeline with addition of emetine for COVID-19; progressed ACER-001, osanetant and EDSIVO™ programs; and entered into stock purchase agreement with Lincoln Park Capital
   The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company  2020/03/20 11:44:59 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA ) Centogene NV (NASDAQ: CNTG ) Gilead Sciences, Inc. (NASDAQ: GILD ) Imara Inc (NASDAQ: IMRA ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Down In The Dumps (Biotech stocks that hit 52-week lows March 19.) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Acer Therapeutics Inc (NASDAQ: ACER ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aikido Pharma Inc (NASDAQ: AIKI ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Amphastar Pharmaceuticals Inc (NASDAQ: AMPH ) Anika Therapeutics Inc (NASDAQ: ANIK ) Anixa Biosciences Inc (NASDAQ: ANIX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Antares Pharma Inc (NASDAQ: ATRS ) Apyx Medical Corp (NASDAQ: APYX ) Arca Biopharma Inc (NASDAQ: ABIO ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) aTyr Pharma Inc (NASDAQ: LIFE ) AVEO Pharmaceuticals, Inc.
   Competition Council president Bogdan Chiritoiu elected to ACER Board of Directors  2019/11/15 21:53:58 Stiri pe surse
President of the Competition Council, Bogdan Chiritoiu, was elected on Friday as a member of the Board of Directors of the European Agency for the Cooperation of Energy Regulators (ACER). Citește mai departe…
   Acer Therapeutics rallies on encouraging ACER-001 data (NASDAQ:ACER)  2020/07/09 12:22:05 Seeking Alpha
Thinly traded nano cap Acer Therapeutics (NASDAQ:ACER) jumps 20% premarket on modestly higher volume in reaction to results from a food effect study in 36
   The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Acer Therapeutics Inc. Investors (ACER)  2020/06/24 17:53:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $ACER #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Acer Therapeutics Inc. (“Acer” or the “Company”) (NASDAQ: ACER) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click here to participate. On June 25, 2019, the Company disclosed receipt of a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration rejecting its new drug application for EDSIVO,
   Acer Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update  2020/05/14 20:01:00 GlobeNewswire
Expanded pipeline with addition of emetine for COVID-19; progressed ACER-001, osanetant and EDSIVO™ programs; and entered into stock purchase agreement with Lincoln Park Capital
   The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company  2020/03/20 11:44:59 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA ) Centogene NV (NASDAQ: CNTG ) Gilead Sciences, Inc. (NASDAQ: GILD ) Imara Inc (NASDAQ: IMRA ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Down In The Dumps (Biotech stocks that hit 52-week lows March 19.) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Acer Therapeutics Inc (NASDAQ: ACER ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aikido Pharma Inc (NASDAQ: AIKI ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Amphastar Pharmaceuticals Inc (NASDAQ: AMPH ) Anika Therapeutics Inc (NASDAQ: ANIK ) Anixa Biosciences Inc (NASDAQ: ANIX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Antares Pharma Inc (NASDAQ: ATRS ) Apyx Medical Corp (NASDAQ: APYX ) Arca Biopharma Inc (NASDAQ: ABIO ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) aTyr Pharma Inc (NASDAQ: LIFE ) AVEO Pharmaceuticals, Inc.
   Competition Council president Bogdan Chiritoiu elected to ACER Board of Directors  2019/11/15 21:53:58 Stiri pe surse
President of the Competition Council, Bogdan Chiritoiu, was elected on Friday as a member of the Board of Directors of the European Agency for the Cooperation of Energy Regulators (ACER). Citește mai departe…
   The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Acer Therapeutics Inc. Investors (ACER)  2020/06/24 17:53:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $ACER #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Acer Therapeutics Inc. (“Acer” or the “Company”) (NASDAQ: ACER) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click here to participate. On June 25, 2019, the Company disclosed receipt of a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration rejecting its new drug application for EDSIVO,
   Acer Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update  2020/05/14 20:01:00 GlobeNewswire
Expanded pipeline with addition of emetine for COVID-19; progressed ACER-001, osanetant and EDSIVO™ programs; and entered into stock purchase agreement with Lincoln Park Capital
   The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company  2020/03/20 11:44:59 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA ) Centogene NV (NASDAQ: CNTG ) Gilead Sciences, Inc. (NASDAQ: GILD ) Imara Inc (NASDAQ: IMRA ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Down In The Dumps (Biotech stocks that hit 52-week lows March 19.) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Acer Therapeutics Inc (NASDAQ: ACER ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aikido Pharma Inc (NASDAQ: AIKI ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Amphastar Pharmaceuticals Inc (NASDAQ: AMPH ) Anika Therapeutics Inc (NASDAQ: ANIK ) Anixa Biosciences Inc (NASDAQ: ANIX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Antares Pharma Inc (NASDAQ: ATRS ) Apyx Medical Corp (NASDAQ: APYX ) Arca Biopharma Inc (NASDAQ: ABIO ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) aTyr Pharma Inc (NASDAQ: LIFE ) AVEO Pharmaceuticals, Inc.
   Competition Council president Bogdan Chiritoiu elected to ACER Board of Directors  2019/11/15 21:53:58 Stiri pe surse
President of the Competition Council, Bogdan Chiritoiu, was elected on Friday as a member of the Board of Directors of the European Agency for the Cooperation of Energy Regulators (ACER). Citește mai departe…
   Acer Therapeutics (NASDAQ:ACER) Announces Quarterly Earnings Results  2019/11/15 00:02:41 Modern Readers
Acer Therapeutics (NASDAQ:ACER) posted its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.52) earnings per share for the quarter, beating the consensus estimate of ($0.57) by $0.05, Yahoo Finance reports. Shares of ACER stock traded down $0.27 on Thursday, hitting $3.13. 54,906 shares of the company’s stock traded hands, compared to its average […]

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 オペクサ・セラピュ―ティクス ACER Acer Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)